{
  "zip": "02138",
  "sector": "Healthcare",
  "fullTimeEmployees": 1,
  "longBusinessSummary": "Pathfinder Cell Therapy, Inc., a development stage regenerative medicine company, focuses on developing novel cell-derived and related therapies for the treatment of various diseases and medical conditions characterized by organ-specific cell damage. It identifies diabetes, renal disease, myocardial infarction, peripheral vascular disease, and other diseases as potential indications for therapies based on its technology. The company was founded in 2008 and is headquartered in Cambridge, Massachusetts.",
  "city": "Cambridge",
  "phone": "617-245-0289",
  "state": "MA",
  "country": "United States",
  "companyOfficers": [],
  "website": "http://www.pathfindercelltherapy.com",
  "maxAge": 1,
  "address1": "12 Bow Street",
  "industry": "Biotechnology",
  "previousClose": 0.0058,
  "regularMarketOpen": 0.0097,
  "twoHundredDayAverage": 0.00274971,
  "trailingAnnualDividendYield": null,
  "payoutRatio": 0,
  "volume24Hr": null,
  "regularMarketDayHigh": 0.0097,
  "navPrice": null,
  "averageDailyVolume10Day": 6635,
  "totalAssets": null,
  "regularMarketPreviousClose": 0.0058,
  "fiftyDayAverage": 0.002898485,
  "trailingAnnualDividendRate": null,
  "open": 0.0097,
  "averageVolume10days": 6635,
  "expireDate": null,
  "yield": null,
  "algorithm": null,
  "dividendRate": null,
  "exDividendDate": null,
  "beta": -0.47584,
  "circulatingSupply": null,
  "startDate": null,
  "regularMarketDayLow": 0.0047,
  "priceHint": 4,
  "currency": "USD",
  "regularMarketVolume": 139117,
  "lastMarket": null,
  "maxSupply": null,
  "openInterest": null,
  "marketCap": 1621890,
  "volumeAllCurrencies": null,
  "strikePrice": null,
  "averageVolume": 26005,
  "priceToSalesTrailing12Months": null,
  "dayLow": 0.0047,
  "ask": 0,
  "ytdReturn": null,
  "askSize": 0,
  "volume": 139117,
  "fiftyTwoWeekHigh": 0.0097,
  "forwardPE": null,
  "fromCurrency": null,
  "fiveYearAvgDividendYield": null,
  "fiftyTwoWeekLow": 0.0008,
  "bid": 0,
  "tradeable": false,
  "dividendYield": null,
  "bidSize": 0,
  "dayHigh": 0.0097,
  "exchange": "PNK",
  "shortName": "PATHFINDER CELL THERAPY INC",
  "longName": "Pathfinder Cell Therapy, Inc.",
  "exchangeTimezoneName": "America/New_York",
  "exchangeTimezoneShortName": "EST",
  "isEsgPopulated": false,
  "gmtOffSetMilliseconds": "-18000000",
  "underlyingSymbol": null,
  "quoteType": "EQUITY",
  "symbol": "PFND",
  "underlyingExchangeSymbol": null,
  "headSymbol": null,
  "messageBoardId": "finmb_113631469",
  "uuid": "103f4334-c7c7-36ce-b013-f4896ac66d6a",
  "market": "us_market",
  "annualHoldingsTurnover": null,
  "enterpriseToRevenue": null,
  "beta3Year": null,
  "profitMargins": 0,
  "enterpriseToEbitda": -11.068,
  "52WeekChange": null,
  "morningStarRiskRating": null,
  "forwardEps": null,
  "revenueQuarterlyGrowth": null,
  "sharesOutstanding": 667161024,
  "fundInceptionDate": null,
  "annualReportExpenseRatio": null,
  "bookValue": -0.01,
  "sharesShort": null,
  "sharesPercentSharesOut": null,
  "fundFamily": null,
  "lastFiscalYearEnd": 1419984000,
  "heldPercentInstitutions": 0,
  "netIncomeToCommon": -1080000,
  "trailingEps": -0.002,
  "lastDividendValue": null,
  "SandP52WeekChange": null,
  "priceToBook": null,
  "heldPercentInsiders": 0,
  "nextFiscalYearEnd": 1483142400,
  "mostRecentQuarter": 1443571200,
  "shortRatio": null,
  "sharesShortPreviousMonthDate": null,
  "floatShares": null,
  "enterpriseValue": 8544656,
  "threeYearAverageReturn": null,
  "lastSplitDate": null,
  "lastSplitFactor": null,
  "legalType": null,
  "morningStarOverallRating": null,
  "earningsQuarterlyGrowth": null,
  "dateShortInterest": null,
  "pegRatio": null,
  "lastCapGain": null,
  "shortPercentOfFloat": null,
  "sharesShortPriorMonth": null,
  "category": null,
  "fiveYearAverageReturn": null,
  "regularMarketPrice": 0.0097,
  "logo_url": "https://logo.clearbit.com/pathfindercelltherapy.com"
}